Beta Carotene, Vitamin E Meta-Analysis Challenged By CRN, NNFA
This article was originally published in The Tan Sheet
Executive Summary
Cleveland Clinic researchers Deepak Vivekananthan, et al. call for a halt to clinical studies on beta carotene and heart disease prevention "because of its risks" in the June 14 issue of The Lancet
You may also be interested in...
Vitamin A, C, E Supplements For CVD, Cancer Without Sufficient Evidence
"The evidence is insufficient to recommend for or against the use of supplements" containing vitamins A, C, or E and certain vitamin combinations for the prevention of cancer or cardiovascular disease, the U.S. Preventive Services Task Force has determined
Vitamin A, C, E Supplements For CVD, Cancer Without Sufficient Evidence
"The evidence is insufficient to recommend for or against the use of supplements" containing vitamins A, C, or E and certain vitamin combinations for the prevention of cancer or cardiovascular disease, the U.S. Preventive Services Task Force has determined
Vitamin A, C, E Supplements For CVD, Cancer Without Sufficient Evidence
"The evidence is insufficient to recommend for or against the use of supplements" containing vitamins A, C, or E and certain vitamin combinations for the prevention of cancer or cardiovascular disease, the U.S. Preventive Services Task Force has determined